Oral daily med for RR/MS

This is to all my friends and passerby's who haven't tried any other therapy for RR/MS!!!  I received this in the mail the oter day from Teva.  As a member of Shared Solutions®, we thought you might be interested in learning about a global research study - Bravo - that is now under way to explore an investigational once-daily oral drug for relapsing-remitting multiple sclerosis (RRMS). If you: •   are between 18 and 55 years old, •   have a confirmed diagnosis of RRMS, •   have had at least one relapse in the last 12 months or two relapses in the last 24 months, •   and, have never been treated with interferon medications (Avonex®, Betaseron®, Rebif®), then you may be eligible to participate in the Bravo study. Over the next 2 years, participants in the Bravo study will: •         Be randomly assigned to receive either study drug, an approved MS therapy injected once weekly, or a placebo (inactive capsule or sugar pill) at no charge. •         Receive study-related physical exams, MS-related assessments and laboratory services at no charge. •         Be monitored by a qualified medical team from a leading healthcare facility in your area. •         Attend 12 study visits during a 2-year period. Call 800-840-5601 or visit www.TevaClinicalTrials.cxDm/Bravo for more information.